A Dose Block-randomized, Doubled, Placebo-controlled, Single Dose, Dose-escalation Clinical Phase I Study to Evaluate the Safety, Pharmacokinetics and Food
Latest Information Update: 18 Sep 2019
At a glance
- Drugs IDP 73152 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- Sponsors Ildong Pharmaceutical
- 11 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrial.gov
- 24 Jul 2013 New trial record
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.